Boiron - Revision history

Omikronn: moved from category:Homeopathy to category:Homoeopathy

2012-03-10T17:58:12Z

moved from category:Homeopathy to category:Homoeopathy

Halbmond: /* Oscillococcinum */

2011-08-20T21:05:09Z

Oscillococcinum

Halbmond at 20:58, 20 August 2011

2011-08-20T20:58:09Z

Heimdall at 12:50, 20 August 2011

2011-08-20T12:50:05Z

Halbmond at 12:25, 20 August 2011

2011-08-20T12:25:22Z

Heimdall: Improved sales data, class action complaint added

2011-08-20T09:41:04Z

Improved sales data, class action complaint added

Halbmond: tp

2011-08-18T00:02:55Z

Halbmond: typos

2011-08-17T23:42:11Z

typos

Heimdall at 21:21, 17 August 2011

2011-08-17T21:21:18Z

Heimdall at 21:14, 17 August 2011

2011-08-17T21:14:06Z

← Older revision		Revision as of 17:58, 10 March 2012
Line 74:		Line 74:

	[[category:Company]]		[[category:Company]]
−	[[category:~~Homeopathy~~]]	+	[[category:Homoeopathy]]

@@ Line 27: / Line 27: @@
 :''Main results - ... There was no evidence that homoeopathic treatment can prevent influenza-like syndrome...Oscillococcinum treatment reduced the length of influenza illness by 0.28 days (95% CI 0.50 to 0.06). Oscillococcinum also increased the chances that a patient considered treatment to be effective (RR 1.08; 95% CI 1.17 to 1.00)...Authors' conclusions - Though promising, the data were not strong enough to make a general recommendation to use Oscillococcinum for first-line treatment of influenza and influenza-like syndromes. Further research is warranted but the required sample sizes are large. Current evidence does not support a preventative effect of Oscillococcinum-like homeopathic medicines in influenza and influenza-like syndromes.''<ref>Andrew Vickers, Claire Smith: ''Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes'', The Cochrane Library, 15.4.2009, DOI: 10.1002/14651858.CD001957.pub3 [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001957.pub3/abstract abstract]</ref>
-Still, the review concluded, that further research was warranted. It was criticized heavily for this conclusion and the review was eventually withdrawn.<ref>[http://www.ncbi.nlm.nih.gov/pubmed/19588329 WITHDRAWN: Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes.], PubMed</ref><ref>[http://www.sciencebasedmedicine.org/index.php/homeopathic-thuggery/ Homeopathic Thuggery], Steven Novella, Science-Based Medicine</ref>
+The review, however, concluded that further research was warranted. It was criticized heavily for this conclusion and was withdrawn eventually.<ref>[http://www.ncbi.nlm.nih.gov/pubmed/19588329 WITHDRAWN: Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes.], PubMed</ref><ref>[http://www.sciencebasedmedicine.org/index.php/homeopathic-thuggery/ Homeopathic Thuggery], Steven Novella, Science-Based Medicine</ref>
 In August 2011 a class action complaint was filed in California:

@@ Line 3: / Line 3: @@
 French pharmaceutical company '''Boiron''' is the world largest manufacturer of [[Homeopathy|homeopathic]] products. Branches of the listed company exist in 59&nbsp;countries. However, Boiron has no presence in German speaking countries.
-In 2009, Boiron had a turnover of 526&nbsp;million Euros (91&nbsp;million Euros profit) with a slight decrease to 520&nbsp;million Euros in 2010. In 2010, turnover in France amounted to 279&nbsp;million Euros and Boiron employed a workforce of 4,081 persons. The majority of shares is held by the Boiron family, the General manager and the chairman of the board of directors also are members of this family. Boiron spent about 128 million Euro on marketing in 2010 but only 6.3 million on research(pharmaceutical companies in general spend around twice as much on marketing as research) - a ratio of 20 to 1.<ref name='Report2010' />
+In 2009, Boiron had a turnover of 526&nbsp;million Euros (91&nbsp;million Euros profit) with a slight decrease to 520&nbsp;million Euros in 2010. In 2010, turnover in France amounted to 279&nbsp;million Euros and Boiron employed a workforce of 4,081 persons. The majority of shares is held by the Boiron family, the general manager and the chairman of the board of directors are members of this family as well. Boiron spent about 128 million Euro on marketing in 2010 but only 6.3 million on research (pharmaceutical companies in general spend around twice as much on marketing than on research) - a ratio of 20 to 1.<ref name='Report2010' />
 In June 2005 Dolisos Laboratories, another manufacturer of homeopathic products, was bought by Boiron.

@@ Line 3: / Line 3: @@
 French pharmaceutical company '''Boiron''' is the world largest manufacturer of [[Homeopathy|homeopathic]] products. Branches of the listed company exist in 59&nbsp;countries. However, Boiron has no presence in German speaking countries.
-In 2009, Boiron had a turnover of 526&nbsp;million Euros (91&nbsp;million Euros profit) with a slight decrease to 520&nbsp;million Euros in 2010. In 2010, turnover in Francce amounted to 279&nbsp;million Euros. In 2010, Boiron employed a workforce of 4,081 persons. The majority of shares is held by the Boiron family, the managing director also is a member of this family.<ref name='Report2010' />
+In 2009, Boiron had a turnover of 526&nbsp;million Euros (91&nbsp;million Euros profit) with a slight decrease to 520&nbsp;million Euros in 2010. In 2010, turnover in France amounted to 279&nbsp;million Euros and Boiron employed a workforce of 4,081 persons. The majority of shares is held by the Boiron family, the General manager and the chairman of the board of directors also are members of this family. Boiron spent about 128 million Euro on marketing in 2010 but only 6.3 million on research(pharmaceutical companies in general spend around twice as much on marketing as research) - a ratio of 20 to 1.<ref name='Report2010' />
 In June 2005 Dolisos Laboratories, another manufacturer of homeopathic products, was bought by Boiron.
 Their range of articles include classic homeopathic preparations according to [[Samuel Hahnemann|Hahnemann]] as well as so called "poly"-preparations from  [[homeopathic combination remedies]].
 ==History==
@@ Line 25: / Line 26: @@
 :''Main results - ... There was no evidence that homoeopathic treatment can prevent influenza-like syndrome...Oscillococcinum treatment reduced the length of influenza illness by 0.28 days (95% CI 0.50 to 0.06). Oscillococcinum also increased the chances that a patient considered treatment to be effective (RR 1.08; 95% CI 1.17 to 1.00)...Authors' conclusions - Though promising, the data were not strong enough to make a general recommendation to use Oscillococcinum for first-line treatment of influenza and influenza-like syndromes. Further research is warranted but the required sample sizes are large. Current evidence does not support a preventative effect of Oscillococcinum-like homeopathic medicines in influenza and influenza-like syndromes.''<ref>Andrew Vickers, Claire Smith: ''Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes'', The Cochrane Library, 15.4.2009, DOI: 10.1002/14651858.CD001957.pub3 [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001957.pub3/abstract abstract]</ref>
 In August 2011 a class action complaint was filed in California:
@@ Line 47: / Line 50: @@
 According to BMJ, Boiron is "monitoring all media including the web to see what is being said about our company".
-−
 {{OtherLang|fr=Boiron|ge=Boiron|en=Boiron}}
@@ Line 64: / Line 66: @@
 *http://www.sciencebasedmedicine.org/index.php/homeopathic-thuggery
 *http://www.guardian.co.uk/science/blog/2010/feb/04/homeopathic-association-evidence-commons-committee
 ----------------------------------
 *http://blog.psiram.com/?p=3832

@@ Line 3: / Line 3: @@
 French pharmaceutical company '''Boiron''' is the world largest manufacturer of [[Homeopathy|homeopathic]] products. Branches of the listed company exist in 59&nbsp;countries. However, Boiron has no presence in German speaking countries.
-In 2009, Boiron had a turnover of 526&nbsp;million Euros (91&nbsp;million euro profit) with a decrease to 520&nbsp;million Euros in 2010. In 2010, turnover in Francce was 279&nbsp;million Euros. In 2010, it employed a workforce of 4,081 persons. The majority of shares is held by the Boiron family, the managing director also is a member of this family.<ref name='Report2010' />
+In 2009, Boiron had a turnover of 526&nbsp;million Euros (91&nbsp;million Euros profit) with a slight decrease to 520&nbsp;million Euros in 2010. In 2010, turnover in Francce amounted to 279&nbsp;million Euros. In 2010, Boiron employed a workforce of 4,081 persons. The majority of shares is held by the Boiron family, the managing director also is a member of this family.<ref name='Report2010' />
 In June 2005 Dolisos Laboratories, another manufacturer of homeopathic products, was bought by Boiron.

@@ Line 1: / Line 1: @@
-[[image:Boiron.jpg|Certificate for alleged student "Donald Duck" as ''Boiron certified specialist'' (Italian: Paperino=Donald Duck, Source: <ref>http://medbunker.blogspot.com/2011/01/paperino-lomeopata.html</ref>)|360px|thumb]]
+[[image:Boiron.jpg|Certificate for alleged student "Donald Duck" as ''Boiron certified specialist'' (Italian: Paperino = Donald Duck, Source: <ref>http://medbunker.blogspot.com/2011/01/paperino-lomeopata.html</ref>)|360px|thumb]]
 French pharmaceutical company '''Boiron''' is the world largest manufacturer of [[Homeopathy|homeopathic]] products. Branches of the listed company exist in 59&nbsp;countries. However, Boiron has no presence in German speaking countries.
-In 2009 Boiron had a turnover of 526&nbsp;million Euros (91&nbsp;million euro profit). In 2004, it employed a workforce of 2,779 people. The majority of shares is held by the Boiron family, the managing director also is a member of this family .
+In 2009, Boiron had a turnover of 526&nbsp;million Euros (91&nbsp;million euro profit). In 2004, it employed a workforce of 2,779 persons. The majority of shares is held by the Boiron family, the managing director also is a member of this family .
 In June 2005 Dolisos Laboratories, another manufacturer of homeopathic products, was bought by Boiron.
-Their range of articles include classic homeopathic preparations according to [[Samuel Hahnemann|Hahnemann]] as well as so called "poly"-preparations from  [[combination homeopathic remedies]].
+Their range of articles include classic homeopathic preparations according to [[Samuel Hahnemann|Hahnemann]] as well as so called "poly"-preparations from  [[homeopathic combination remedies]].
 ==History==
-The actual founder was Parisian pharmacist and homeopathic asherent René Baudry, who founded the "Pharmacie générale homéopathique française" in Paris (boulevard Malesherbes&nbsp;68,&nbsp;8.&nbsp;arrondissement of Paris) in 1911. In 1922, Baudry sold his business and founded a "Laboratoire central homéopathique rhodanien" in Lyon.
+The actual founder was Parisian pharmacist and homeopathic adherent René Baudry, who founded the "Pharmacie générale homéopathique française" in Paris (boulevard Malesherbes&nbsp;68,&nbsp;8.&nbsp;arrondissement of Paris) in 1911. In 1922, Baudry sold his business and founded a "Laboratoire central homéopathique rhodanien" in Lyon.
 The brothers Jean und Henri Boiron (both pharmacists) contacted Baudry later and were employed by him. In 1932, the Boiron brothers founded the "Laboratoire central homéopathique de France" at the aforementioned address which later became the "Laboratoires Homéopathiques Modernes" (LHM).
@@ Line 21: / Line 21: @@
 :Active ingredient: Anas Barbariae Hepatis et Cordis Extractum (extract of Muscovy Duck liver and heart) 200CK HPUS 1×10−400 g. Inactive ingredient: 0.85 g sucrose, 0.15 g lactose (100% sugar)
-Efficacy of Oscillococcinum against influenza is not scientifically proven. A Cochrane review found seven studies on the subject and came to the conclusion that only two of them can be evaluated and no evidence of efficacy could be established:
+Efficacy of Oscillococcinum against influenza is not proven scientifically. A Cochrane review found seven studies on the subject and came to the conclusion that only two of them can be evaluated and no evidence of efficacy could be established:
 :''Main results - ... There was no evidence that homoeopathic treatment can prevent influenza-like syndrome...Oscillococcinum treatment reduced the length of influenza illness by 0.28 days (95% CI 0.50 to 0.06). Oscillococcinum also increased the chances that a patient considered treatment to be effective (RR 1.08; 95% CI 1.17 to 1.00)...Authors' conclusions - Though promising, the data were not strong enough to make a general recommendation to use Oscillococcinum for first-line treatment of influenza and influenza-like syndromes. Further research is warranted but the required sample sizes are large. Current evidence does not support a preventative effect of Oscillococcinum-like homeopathic medicines in influenza and influenza-like syndromes.''<ref>Andrew Vickers, Claire Smith: ''Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes'', The Cochrane Library, 15.4.2009, DOI: 10.1002/14651858.CD001957.pub3 [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001957.pub3/abstract abstract]</ref>
@@ Line 29: / Line 29: @@
 [[image:Blogzero.jpg|Offending article with caricatures promptly removed (note in red letters) at blogzero.it|320px|thumb]]
 [[image:Boiron_Riva2.jpg|left|Threathening letter from Boiron, page 2|thumb]]
-[[image:Boiron3.jpg|Attentive tracking of the thread and reactions to it in the Internet ("Streisand Effekt") at "börsennews.de"<ref>http://winfuture.de/news,64979.html</ref>|320px|thumb]]
+[[image:Boiron3.jpg|Attentive tracking of the thread and reactions to it in the internet ("Streisand Effekt") at "börsennews.de"<ref>http://winfuture.de/news,64979.html</ref>|320px|thumb]]
-The actions against Italian blogger Samuele Riva from Milan by multinational pharmaceutical company Boiron with a budget of millions seem to be an ill-matched fight matching David against Golitath. On July&nbsp;13 and July&nbsp;27 2011, the 28-year-old computer scientist added two ridiculing articles on homeopathy to his blog, titled "Homeopathy - myth and legend" (''omeopatia mito e leggenda'') (Article&nbsp;1: [http://www.blogzero.it/2011/07/13/omeopatia-mito-e-leggenda-1/] Article&nbsp;2: [http://www.blogzero.it/2011/07/27/omeopatia-mito-e-leggenda-2/]). The blogger also showed two pictures of Oscillococcinum with comments. According to the threatening letter of Boiron company, Riva added the following text below the pictures:
+The actions against Italian blogger Samuele Riva from Milan by multinational pharmaceutical company Boiron with a budget of millions seem to be an uneven fight matching David against Golitath. On July&nbsp;13 and July&nbsp;27 2011, the 28-year-old computer scientist added two ridiculing articles on homeopathy to his blog, titled "Homeopathy - myth and legend" (''omeopatia mito e leggenda'') (Article&nbsp;1: [http://www.blogzero.it/2011/07/13/omeopatia-mito-e-leggenda-1/] Article&nbsp;2: [http://www.blogzero.it/2011/07/27/omeopatia-mito-e-leggenda-2/]). The blogger also showed two pictures of Oscillococcinum with comments. According to the threatening letter of Boiron company, Riva added the following text below the pictures:
 *13.7.2011..''Il piu Nulla totale che secondo la Boiron cura l'influenza ... diluito 200K non contiene alcuna molecola di pricipio attivo. ("The absolute nothing which is supposed to cure flu according to Boiron" ... "diluted 200K it does not even contain one molecule of the active substance")

@@ Line 1: / Line 1: @@
 [[image:Boiron.jpg|Certificate for alleged student "Donald Duck" as ''Boiron certified specialist'' (Italian: Paperino=Donald Duck, Source: <ref>http://medbunker.blogspot.com/2011/01/paperino-lomeopata.html</ref>)|360px|thumb]]
-The French pharmaceutical company '''Boiron''' is worlds largest manufacturer of [[Homeopathy|homeopathic]] products. Branches of the listed company exist in 59&nbsp;countries. However, Boiron has no presence in German speaking countries.
+French pharmaceutical company '''Boiron''' is the world largest manufacturer of [[Homeopathy|homeopathic]] products. Branches of the listed company exist in 59&nbsp;countries. However, Boiron has no presence in German speaking countries.
-In 2009 Boiron had a turnover of 526&nbsp;million Euros (91&nbsp;million euro profit). In 2004, it employed a workforce of 2,779 people. The majority of the shares is held by family Boiron, the managing director is also a member of the family .
+In 2009 Boiron had a turnover of 526&nbsp;million Euros (91&nbsp;million euro profit). In 2004, it employed a workforce of 2,779 people. The majority of shares is held by the Boiron family, the managing director also is a member of this family .
-In June 2005 Dolisos Laboratories, another manufacturer of homeopathic products was bought by Boiron.
+In June 2005 Dolisos Laboratories, another manufacturer of homeopathic products, was bought by Boiron.
-Offerings include classic homeopathic preparations after [[Samuel Hahnemann|Hahnemann]] as well as so called "poly"-preparations from  [[combination homeopathic remedies]].
+Their range of articles include classic homeopathic preparations according to [[Samuel Hahnemann|Hahnemann]] as well as so called "poly"-preparations from  [[combination homeopathic remedies]].
 ==History==
-The actual founder was Parisian pharmacist and homeopathic supporter René Baudry in 1911, who founded the "Pharmacie générale homéopathique française" in Paris (boulevard Malesherbes&nbsp;68,&nbsp;8.&nbsp;arrondissement of Paris). In 1922 Baudry sold his business and founded a "Laboratoire central homéopathique rhodanien" in Lyon.
+The actual founder was Parisian pharmacist and homeopathic asherent René Baudry, who founded the "Pharmacie générale homéopathique française" in Paris (boulevard Malesherbes&nbsp;68,&nbsp;8.&nbsp;arrondissement of Paris) in 1911. In 1922, Baudry sold his business and founded a "Laboratoire central homéopathique rhodanien" in Lyon.
-The brothers Jean und Henri Boiron (both pharmacists) contacted Baudry later and were employed by him. In 1932 the brothers Boiron founded at the aforementioned address the "Laboratoire central homéopathique de France" which became later the "Laboratoires Homéopathiques Modernes" (LHM).
+The brothers Jean und Henri Boiron (both pharmacists) contacted Baudry later and were employed by him. In 1932, the Boiron brothers founded the "Laboratoire central homéopathique de France" at the aforementioned address which later became the "Laboratoires Homéopathiques Modernes" (LHM).
-The Boiron-Group was formed in 1967 by a union of several homeopathic manufacturers. The company went public in 1987(Lyon). Boiron took over several other pharmaceutical companies in the following years.
+The Boiron-Group was formed in 1967 by a union of several homeopathic manufacturers. The company went public in 1987 (Lyon). Boiron took over several other pharmaceutical companies during the following years.
 ==Oscillococcinum==
 [[image:Oscillococcinum.jpg|thumb]]
-One of the best known preparations of Boiron is [http://en.wikipedia.org/wiki/Oscillococcinum Oscillococcinum] (''Oscillo''), a milk sugar preparation which is claimed to be effective against flu. The name is derived from a presumption of French physician Joseph Roy (1891–1978) who believed in 1917 during a flu epidemic to have observed the bacterial genus Oscillococcus in the blood of disease patients. Oscillococcinum&nbsp;C200 is the best-selling homeopathic product in the U.S. It is also called "the $20-million duck" there. Annual turnover of the product is $ 20&nbsp;million. The preparation is produced from duck liver, but only a single duck liver is needed for the entire turnover - and even from that a lot is wasted: The potency C200 means the ratio of liver to solution is 1&nbsp;to&nbsp;a number with 400&nbsp;zeros.<ref>http://www.anonym.to/?http://www.quackwatch.com/01QuackeryRelatedTopics/homeo.html</ref> For comparison: The whole universe including earth consists of about 10 to the power of 78 particles. Ingredients of Oscillococcinum:
+One of the best known products of Boiron is [http://en.wikipedia.org/wiki/Oscillococcinum Oscillococcinum] (''Oscillo''), a milk sugar concoction which allegedly is effective against influenza. The name is derived from a presumption of French physician Joseph Roy (1891–1978) who, during a flu epidemic in 1917, believed to have observed the bacterial genus Oscillococcus in the blood of diseased patients. Oscillococcinum&nbsp;C200 is the best-selling homeopathic product in the U.S. It is also called "the $20-million duck" there. Annual turnover of the product is $ 20&nbsp;million. The compound is produced from duck liver, but only a single duck liver is needed for the entire turnover - and even from this one liver, the best part will go wasted: The potency C200 means the ratio of liver to solution is 1&nbsp;to&nbsp;a number with 400&nbsp;zeros.<ref>http://www.anonym.to/?http://www.quackwatch.com/01QuackeryRelatedTopics/homeo.html</ref> For comparison: The whole universe including earth consists of about 10 to the power of 78 particles. Ingredients of Oscillococcinum:
 :Active ingredient: Anas Barbariae Hepatis et Cordis Extractum (extract of Muscovy Duck liver and heart) 200CK HPUS 1×10−400 g. Inactive ingredient: 0.85 g sucrose, 0.15 g lactose (100% sugar)
-Efficacy of Oscillococcinum against influenza is not scientifically proven. A Cochrane-review found seven studies on the subject and came to the conclusion that only two of them can be evaluated and no evidence of efficacy could be demonstrated:
+Efficacy of Oscillococcinum against influenza is not scientifically proven. A Cochrane review found seven studies on the subject and came to the conclusion that only two of them can be evaluated and no evidence of efficacy could be established:
 :''Main results - ... There was no evidence that homoeopathic treatment can prevent influenza-like syndrome...Oscillococcinum treatment reduced the length of influenza illness by 0.28 days (95% CI 0.50 to 0.06). Oscillococcinum also increased the chances that a patient considered treatment to be effective (RR 1.08; 95% CI 1.17 to 1.00)...Authors' conclusions - Though promising, the data were not strong enough to make a general recommendation to use Oscillococcinum for first-line treatment of influenza and influenza-like syndromes. Further research is warranted but the required sample sizes are large. Current evidence does not support a preventative effect of Oscillococcinum-like homeopathic medicines in influenza and influenza-like syndromes.''<ref>Andrew Vickers, Claire Smith: ''Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromes'', The Cochrane Library, 15.4.2009, DOI: 10.1002/14651858.CD001957.pub3 [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD001957.pub3/abstract abstract]</ref>
 ==Lawsuit threats against Boiron-critic and blogger Samuele Riva==
-[[image:Boiron_Riva1.jpg|Threathening letter from Boiron page 1 (click to enlarge)|left|thumb]]
+[[image:Boiron_Riva1.jpg|Threathening letter from Boiron, page 1 (click to enlarge)|left|thumb]]
-[[image:Blogzero.jpg|offending article with promptly removed caricatures (note in red letters) at blogzero.it|320px|thumb]]
+[[image:Blogzero.jpg|Offending article with caricatures promptly removed (note in red letters) at blogzero.it|320px|thumb]]
-[[image:Boiron_Riva2.jpg|left|Threathening letter from Boiron page 2|thumb]]
+[[image:Boiron_Riva2.jpg|left|Threathening letter from Boiron, page 2|thumb]]
 [[image:Boiron3.jpg|Attentive tracking of the thread and reactions to it in the Internet ("Streisand Effekt") at "börsennews.de"<ref>http://winfuture.de/news,64979.html</ref>|320px|thumb]]
-The actions against Italian blogger Samuele Riva from Milan by multinational pharmaceutical company Boiron with millions of budget seem to be an unequal struggle David against Golitath. On July&nbsp;13 and July&nbsp;27 2011 the 28-year-old computer scientist had added two ridiculing articles in his blog about homeopathy with the title "Homeopathy - myth and legend" (''omeopatia mito e leggenda'') (Article&nbsp;1: [http://www.blogzero.it/2011/07/13/omeopatia-mito-e-leggenda-1/] Article&nbsp;2: [http://www.blogzero.it/2011/07/27/omeopatia-mito-e-leggenda-2/]). The blogger also showed to pictures of Oscillococcinum with commentaries. According to the threatening letter by company Boiron Riva had written the following text below the pictures:
+The actions against Italian blogger Samuele Riva from Milan by multinational pharmaceutical company Boiron with a budget of millions seem to be an ill-matched fight matching David against Golitath. On July&nbsp;13 and July&nbsp;27 2011, the 28-year-old computer scientist added two ridiculing articles on homeopathy to his blog, titled "Homeopathy - myth and legend" (''omeopatia mito e leggenda'') (Article&nbsp;1: [http://www.blogzero.it/2011/07/13/omeopatia-mito-e-leggenda-1/] Article&nbsp;2: [http://www.blogzero.it/2011/07/27/omeopatia-mito-e-leggenda-2/]). The blogger also showed two pictures of Oscillococcinum with comments. According to the threatening letter of Boiron company, Riva added the following text below the pictures:
-*13.7.2011..''Il piu Nulla totale che secondo la Boiron cura l'influenza...diluito 200K non contiene alcuna molecola di pricipio attivo. ("The absolute nothing, which is supposed to cure flu according to Boiron"..."diluted 200K it contains not one molecule of the active substance")
+*13.7.2011..''Il piu Nulla totale che secondo la Boiron cura l'influenza ... diluito 200K non contiene alcuna molecola di pricipio attivo. ("The absolute nothing which is supposed to cure flu according to Boiron" ... "diluted 200K it does not even contain one molecule of the active substance")
-*27.7.2011..''Nuoce gravemente all'intelligenza (di chi lo aquista)..'' ("serious harm to the intelligence (of the buyer)")
+*27.7.2011..''Nuoce gravemente all'intelligenza (di chi lo aquista)..'' ("Serious harm to the intelligence (of the buyer)")
-Italian branch of Boiron acted irritated and threatened with a lawsuit for libel. The blogger removed the pictures from the articles. According to the "British Medical Journal" (BMJ) which collected information about the lawsuit threat and contacted Boiron, Boiron employee Silvia Nencioni had approached the hoster of the blog on Juli&nbsp;28&nbsp;2011 and asked him in writing to remove all references to Boiron and block acces to the articles. Otherwise Boiron would sue. According to Boiron the statements in the articles were “untrue and derogatory both of homeopathy and [the] company,” and responsible for tarnishing the company’s reputation and cause "serious damage". The hoster refused to disclose address and identity of the blogger to Boiron, these information would be disclosed only to government agencies under certain circumstances. Riva commented on the lawsuit threat:
+Boiron's Italian branch acted irritated and threatened a lawsuit because of libel. The blogger removed the pictures from the articles. According to the "British Medical Journal" (BMJ) which collected information about the lawsuit threat and contacted Boiron, Boiron employee Silvia Nencioni had approached the blog hoster on Juli&nbsp;28&nbsp;2011 and in writing asked them to remove all references to Boiron and block access to the articles. Otherwise Boiron would sue. According to Boiron, the statements in the articles were “untrue and derogatory both of homeopathy and [the] company,” and responsible for tarnishing the company’s reputation and causing "serious damage". The hoster refused to disclose address and identity of the blogger to Boiron, this information would only be disclosed to government agencies under certain circumstances. Riva commented on the lawsuit threat:
 :''[...] When I was informed of the threatening letter, I removed the pictures and the direct references to the company and its products, while leaving the articles about homeopathy online. I also sent an email to the company telling them I had complied with their requests, but have not received a reply so far [...]'' (cited from BMJ)
-Riva continues to document the progression of the lawsuit threat in his blog [http://www.blogzero.it "blogzero.it"] and also created a website in English, since the affair received international attention: [http://www.blogzero.it/contatti/prova/]. More than a hundred blogs and websites have reported so far (as of Aug. 9 2011) about the lawsuit threat. Riva reports in his blog, said articles were read bei less than 150 people in the first 56 hours after release. After the lawsuit threat his blog is visited now several thousand times per day (as of Aug. 9 2011) <ref>http://www.blogzero.it/2011/08/09/caso-boiron-contro-blogzero-blog/</ref>. A long and growing list of blogs support Riva now: [http://www.blogzero.it/2011/08/12/boiron-vs-blog-elenco-siti-supporter/ List of supporters - further supporters can register there].
+Riva continues to document the progression of the lawsuit threat in his blog [http://www.blogzero.it "blogzero.it"] and also created a website in English, since the affair gained international attention: [http://www.blogzero.it/contatti/prova/]. More than a hundred blogs and websites have reported about the lawsuit threat so far (as of Aug. 9, 2011). In his blog, Riva reports that said articles were read by less than 150 persons in the first 56 hours after publication. After the lawsuit threat, his blog now gets visited several thousand times per day (as of Aug. 9, 2011) <ref>http://www.blogzero.it/2011/08/09/caso-boiron-contro-blogzero-blog/</ref>. A long and growing list of blogs support Riva meanwhile: [http://www.blogzero.it/2011/08/12/boiron-vs-blog-elenco-siti-supporter/ List of supporters - further supporters can register there].
-According to the BMJ Boiron is "monitoring all media including the web to see what is being said about about our company".
+According to BMJ, Boiron is "monitoring all media including the web to see what is being said about our company".
 {{OtherLang|fr=Boiron|ge=Boiron|en=Boiron}}